Schroder Investment Management Australia

Cranport, founded in 2003 by CEO Stuart Foster, is a family office investment vehicle based in Sydney, primarily focusing on Australian equities with a long bias. The firm specializes in event-driven trading of mid to large-cap equities and employs a disciplined strategy driven by fundamental analysis aimed at achieving double-digit returns over the long term. With a strong emphasis on high-growth sectors such as resources and technology, Cranport actively trades based on both macroeconomic and company-specific catalysts. Their investment process is rooted in rigorous bottom-up analysis to identify companies capable of market capitalisation growth and long-term value enhancement. Generated from the website

BioFarmag Limited, established in 2004, is pioneering a revolutionary non-invasive test for breast cancer detection by utilizing synchrotron X-ray diffraction of hair samples. This innovative approach aims to provide early detection for women from as young as 20 years old, potentially enhancing treatment options and survival rates. The company's technology leverages the unique properties of hair, which can reflect an individual's biomedical and environmental history over time. Currently in trial phases, the BioFarmag Test has shown promising results during its 2000-patient validation trial, achieving an accuracy rate of 69.75% after excluding damaged hair. Generated from the website